Organism name | Desmodium triflorum |
---|---|
Genus | Desmodium |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Desmodium triflorum |
---|---|
Linked NCBI taxonomy ID | 670328 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001059
![]() |
Isovitexin
/ Saponaretin / Homovitexin / 6-C-beta-D-Glucopyranosylapigenin / 6-beta-D-Glucopyranosyl-4',5,7-trihydroxyflavone / 6-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL465360
CHEMBL1601394 |
C049772
|
28 / 20 / 19 | No. 22 | No. 15 |
![]() |
|
C00001110
![]() |
Vitexin
/ Apigenin 8-C-glucoside / 8-D-Glucosyl-4',5,7-trihydroxyflavone / 8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL487417
CHEMBL1332209 CHEMBL1357921 |
16 / 4 / 8 | No. 22 | No. 15 |
![]() |
||
C00001435
![]() |
Tyramine
|
CHEMBL11608
|
D014439
|
23 / 11 / 6 | 6 / 9 | No. 936 | No. 6 |
![]() |
C00002074
![]() |
Stachydrine
|
CHEMBL394450
CHEMBL1456892 CHEMBL1986864 |
10 / 8 / 12 | No. 2627 | No. 1 |
![]() |
||
C00001555
![]() |
Trigonelline
|
CHEMBL350675
|
C009560
|
3 / 1 / 0 | No. 3681 | No. 1 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001110 C00001435 C00002074 | 1 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001059 C00001110 C00001435 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001059 C00001110 C00001435 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001110 C00001435 C00002074 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001110 C00001435 C00002074 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001110 C00001435 C00002074 | 0 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001110 C00001435 C00002074 | 0 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001059 C00001110 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001059 C00001435 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001059 C00001110 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001059 C00001110 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001059 C00001110 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001059 C00001555 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00001059 C00002074 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001059 C00002074 | 1 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001059 C00001435 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001059 C00001110 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001059 C00001110 | 1 / 4 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001059 C00001110 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00001110 C00001435 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001555 | 0 / 0 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001435 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00001110 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001059 | 7 / 3 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002074 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001059 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001435 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002074 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00001435 | 4 / 2 |
P56817 | Beta-secretase 1 | A1A | C00001435 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001059 | 2 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001059 | 0 / 0 |
P30989 | Neurotensin receptor type 1 | Neurotensin receptor | C00001059 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001435 | 2 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001059 | 1 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001435 | 1 / 1 |
Q96RJ0 | Trace amine-associated receptor 1 | Trace amine receptor | C00001435 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001059 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00002074 | 3 / 2 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001059 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001555 | 0 / 0 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001435 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001059 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001435 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001059 | 1 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00001059 | 1 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00001059 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001435 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001435 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001435 | 2 / 0 |
O75751 | Solute carrier family 22 member 3 | Unclassified protein | C00001435 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001059 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001059 | 2 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
4128 | MAOA, MAO-A | monoamine oxidase A (EC:1.4.3.4) |
C00001435
|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001435
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001435
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001435
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001435
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001435
|
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P14416
|
#300615 | Brunner syndrome |
P21397
|
#114500 | Colorectal cancer; crc |
Q14191
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00296 | Defects in RecQ helicases |
Q14191
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D009202 | Cardiomyopathies |
C00001435
|
D002543 | Cerebral Hemorrhage |
C00001435
|
D002637 | Chest Pain |
C00001435
|
D006973 | Hypertension |
C00001435
|
D007022 | Hypotension |
C00001435
|
D008881 | Migraine Disorders |
C00001435
|
D015878 | Mydriasis |
C00001435
|
D011041 | Poisoning |
C00001435
|
D013610 | Tachycardia |
C00001435
|